Avalus Ultra Post-Approval Study (PAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 190 participants.

Also called NCT06506903

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 190 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06506903
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06506903. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-20 (actual); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Avalus Ultra Post-Approval Study (PAS)
Condition
Aortic Valve Disease
Intervention (Device)
Medtronic Avalus Ultra
Lead sponsor
Medtronic Cardiac Surgery (class: industry)

Record details

Record id
cardio:ct-nct06506903
Content hash
7d50f3cd29d51e53015e8ce45696e1c2574a86dc373728c66bb75b696db22e94